symptom inventory

symptom inventory

A list of findings or patterns common to particular illnesses or diseases, e.g., psychological illnesses, traumatic injuries, or neoplastic diseases. Symptom inventories are used to assess or screen patients, to assign them to treatment groups, and to randomize groups of individuals by their similarities or differences so that they may be compared in research.
References in periodicals archive ?
Ledo and colleagues (2013) studied the psychopathological impact on this population a year after the PST protocol and noticed that values decreased significantly one year after the implementation of the PST, regardless of the disease studied or the test result; however, for all Brief Symptom Inventory (BSI) dimensions and global indexes, significantly higher values were found than those of control groups.
Detailed medical history and small fiber neuropathy were investigated, and symptom inventory questionnaire was conducted, as well as the visual analog scale.
1) Brief Symptom Inventory (BSI) (Derogatis & Lazarus, 1994; Derogatis & Melisaratos, 1983).
Brief Symptom Inventory The BSI (Derogatis, 1993) is a 53-item self-report symptom inventory.
Moreover, 42% of patients with a static PGA of 0 were 100% symptom free every day from week 10 to week 12 of the study as defined by a score of 0 on the eight-item Psoriasis Symptom Inventory, compared with 12% of patients with a static PGA of 1.
DASS Anxiety subscale, Brief Symptom Inventory Anxiety subscale [Derogatis, 1993]).
The following personal characteristics were considered: age group (18-29, 30-49, 50 years and over); skin color (white, black/brown, yellow/ indigenous); whether the individual practiced a religion and frequency (yes, frequently; yes, sometimes; no); marital status (single, married, widow(er), separated); existence of symptoms of depression assessed using the Beck Depression Inventory21; and existence of symptoms of stress measured using the Lipp Stress Symptom Inventory for Adults.
Those who volunteered to participate in the study were administered: Brief Symptom Inventory (BSI; Derogatis and Melisaratos, 1983) and Brief COPE (Carver, 1997), translated into indigenous language.
Primary objective of our study was to find out the drug with maximum efficacy in reducing neuropathic pain, as measured by mean Neuropathic Pain Symptom Inventory (NPSI) score in a treatment group.
The PFDI-20 is both a symptom inventory and a measure of the degree of bother and distress (QOL) caused by pelvic floor symptoms.
Parental depression was assessed using the depression subscale (Derogatis & Melisaratos, 1983) of the Brief Symptom Inventory (BSI-Dep).
Outcomes were measured at 4 and 12 weeks by using the IBS Symptom Severity Scale, Brief Symptom Inventory, and IBS Quality of Life questionnaire.